Evening of Hope

Gilead increases limits on its assistance programs for PrEP

On July 23, 2018, Gilead (the manufacturer of Truvada) announced two major changes to their PrEP assistance programs. These changes will help address ongoing affordability challenges that many people are facing with today’s rising costs of health insurance. First, the eligibility limit for the Copay Coupon…Read More

IAS2018: Bay Area, U.S. & GlobaRights Advocates Demand 2020 International AIDS Conference Be Removed from U.S.

Re-posted from Positive Women’s Network **FOR IMMEDIATE RELEASE** Contact: Cecilia Chung +1.415.902.0216, cecilia@transgenderlawcenter.org Naina Khanna +1.510.681.1169, nkhanna@pwn-usa.org George Ayala +, gayala@mpactglobal.org BAY AREA, U.S. AND GLOBAL HUMAN RIGHTS ADVOCATES DEMAND 2020 INTERNATIONAL AIDS CONFERENCE BE REMOVED FROM U.S. They cite danger for potential participants and human…Read More

IAS2018: Communique of the Kigali Dolutegravir Stakeholder Meeting of African Women Living with HIV, hosted by AfroCAB

We, the thirty-nine women living with HIV representing 18 countries, met in Kigali on July 13 and 14 to discuss the potential neural tube defect (NTD) safety signal in women taking dolutegravir (DTG) at conception and develop a joint position on behalf of women for access…Read More

FDA approves new single tablet regimen Symtuza for treating chronic HIV infection

On July 17, 2018, the Food and Drug Administration approved a new single tablet regimen (STR) for treating chronic HIV, called Symtuza. The once-a-day, full-regimen pill contains four drugs: the protease inhibitor darunavir (Prezista) + the booster cobicistat (Tybost) + the NRTIs emtricitabine (FTC/Emtriva) and tenofovir…Read More

California DPH issues statewide standing order to reduce opioid deaths with naloxone

Issued by the California Department of Public Health on July 5, 2018: Many organizations and programs in California can help reduce deaths associated with opioid overdose by distributing naloxone, however some find it difficult to obtain the required standing order from a physician to do so….Read More

New Medi-Cal policy issued for treating hepatitis C

On July 3, 2018, California Department of Public Health issued the following communication. Dear Community Partners: I am very excited to announce that today the California Department of Health Care Services (DHCS) released a new hepatitis C treatment policy for Medi-Cal beneficiaries. The new Medi-Cal policy…Read More

NASTAD recognizes Project Inform’s Anne Donnelly during 2018 Annual Meeting

ORIGINAL POST: www.nastad.org Every year during our Annual Meeting, NASTAD celebrates the accomplishments of our members and partners with a series of awards. This year, we’re so proud to recognize the amazing accomplishments of Peter Whiticar, Diana Jordan, Anne Donnelly, and Dr. Theo Hodge. NASTAD Partnership…Read More